Exceprt: Since the week of February 18, 2013, through the last available listing in April 2013, the FDA's Public Calendar has listed Dr. Brenner-Gati as the Acting Deputy Commissioner for Medical Products and Tobacco with no significant meetings. However, the FDA posted on its website the FDA organizational chart approved and signed on March 4, 2013, by the FDA Reorganization Coordinator listing the position of Deputy Commissioner for Medical Products as vacant.
WASHINGTON, DC – House Energy and Commerce Committee leaders today expressed concern with recent press reports that Health and Human Services Secretary Kathleen Sebelius has solicited funding from private companies to help implement the health care law.
To read the letter to HHS, click here. To read the letter to the following companies, click here.
Shining Light on the EPA’s Rule Making By Rep. Bill Cassidy (R-LA)
OBAMACARE RATE SHOCKER: Committee Surveys Leading Insurance Companies—Obamacare to Cause Premiums to Spike Nationwide, as High as 400 PercentMay 13, 2013 | Press Release
WASHINGTON, DC – Today, the House Committee on Energy and Commerce announced its hearing and vote schedule for the week of May 13, 2013. The committee will mark up three pieces of legislation pertaining to electric reliability, animal drug user fees, and the security of our nation’s prescription drug supply.